HealthEquityFRA:2HE -4.00%92 Interest Coverage is 8.27 as of Apr. 2026, which is 113% above its 10-year median of 3.88. GuruFocus rates FRA:2HE with a GF Score™ of 92/100 and a GF Value™ of €83.82. The stock has 1 warning sign investors should review. Among 452 Healthcare Providers & Services companies, HealthEquity ranks worse than 57.08% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. HealthEquity's
Operating Income
for the
three
months ended in Apr. 2026 was €89 Mil. HealthEquity's Interest Expense for the
three
months ended in Apr. 2026 was €-11 Mil.
HealthEquity's interest coverage for the quarter that ended in Apr. 2026 was 8.27.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for HealthEquity's Interest Coverage or its related term are showing as below:
FRA:2HE'
s Interest Coverage Range Over the Past 10 Years
Min: 0.78 Med: 3.88 Max: No Debt
Current: 6.33
FRA:2HE's Interest Coverage is ranked worse than 57.08% of 452
companies
in the Healthcare Providers & Services industry
Industry Median: 7.99
vs FRA:2HE: 6.33
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
HealthEquity Interest Coverage Related Terms
HealthEquity Interest Coverage Historical Data
* Premium members only.
The historical data trend for HealthEquity's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:2HE vs HNGE, TEM, TXG: Interest Coverage Comparison
For the Health Information Services subindustry, HealthEquity's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Interest Coverage distribution charts can be found below:
* The bar in red indicates where HealthEquity's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity (FRA:2HE) has a Interest Coverage of 8.27 as of Apr. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on HealthEquity and its competitors. This is 113% above median its historical median of 3.88. Over the past decade, HealthEquity's Interest Coverage has ranged from 0.78 to 10,000.00. According to the industry distribution chart, HealthEquity ranks #258 out of 452 companies in the Healthcare Providers & Services industry, placing it in the top 57.1%.
Is HealthEquity's Interest Coverage too high?
HealthEquity's current Interest Coverage of 8.27 is 113% above median its 10-year median of 3.88. Over the past 10 years, this metric has ranged from a low of 0.78 to a high of 10,000.00. The Healthcare Providers & Services industry median Interest Coverage is 7.99. HealthEquity's value of 8.27 is 3.5% above this industry median. Based on the distribution chart, HealthEquity ranks #258 out of 452 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthEquity has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Interest Coverage compare to HNGE and TEM?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #258 out of 452 companies for Interest Coverage. This places HealthEquity in the lower half of its industry. The industry median Interest Coverage is 7.99. HealthEquity's value of 8.27 is 3.5% above this benchmark. Historically, HealthEquity's own Interest Coverage has ranged from 0.78 to 10,000.00 over the past decade. While the company's 10-year median is 3.88 vs. the industry median of 7.99, HealthEquity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.99, based on 452 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current Interest Coverage of 8.27 is 3.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current Interest Coverage is 8.27, which is 113% above median its own 10-year median of 3.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Interest Coverage of 8.27. The stock's GF Value™ is €83.82, compared to a current price of €72.00 — trading 14.1% below its estimated fair value. The current Interest Coverage is 8.27, which is 113% above median its 10-year median of 3.88 and 3.5% above the Healthcare Providers & Services industry median of 7.99. HealthEquity's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Interest Coverage is 8.27 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €72.00 is trading 14.1% below its estimated GF Value™ of €83.82.
Key valuation signals for FRA:2HE:
Interest Coverage: 8.27 (113% above median its 10-year median of 3.88)
GF Value™: €83.82 vs. price of €72.00 (14.1% below fair value)
Industry Position: 3.5% above the Healthcare Providers & Services median (#258 of 452)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
92GF Score
Get the complete analysis for FRA:2HE
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
